Business Standard brings top headlines on Thursday
Govt likely to give partial indemnity to company
Pfizer says it is expanding testing of its COVID-19 vaccine in children younger than 12.
Taking two doses of the Pfizer-BioNTech and Moderna's mRNA-based vaccines, authorised by the Food and Drug Administration, can reduce the risk of coronavirus infection by 91 per cent
Around 10 per cent of these beds have been set up to meet the requirements of Covid-19 paediatric patients.
The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age
People fully vaccinated with two doses of the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant
India is looking forward to WHO's nod for vaccine manufactured by Bharat Biotech
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, SII has also sought protection against liabilities
Used to treat only mild to moderate disease in high-risk Covid-19 patients, doctors feel the treatment can bolster the fight against severe disease
According to a study, there were 275 cases of myocarditis identified between December 2020, when the vaccination drive began, and May 2021, including 148 cases within a month after vaccination.
Only around 3 per cent of the population has been inoculated till now. The Indian government is expected to grant foreign vaccine makers Pfizer and Moderna indemnity against legal proceedings
Earlier, vaccines that had completed clinical studies outside the country were required to carry out "bridging trials" or limited clinical trials on the Indian population
The vaccine, named PTX-COVID19-B, is under development in Canada; the deal assumes significance as this gives India access to the mRNA tech
The SAD chief accused Prime Minister Narendra Modi and CM Singh of having failed to fulfil their duty to provide vaccines to people.
Inoculating children and young people is considered a critical step toward reaching "herd immunity" and taming the pandemic
Pfizer's indemnity request is also being looked into by the government
Companies, including Moderna and Pfizer, have said they will deal only with the Centre and not state governments
Covaxin production by Bharat Biotech is being increased: Paul
Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer Covid-19 vaccine as soon as possible to inoculate children